Literature DB >> 25083416

Virtual Reality Functional Capacity Assessment In Schizophrenia: Preliminary Data Regarding Feasibility and Correlations with Cognitive and Functional Capacity Performance.

Stacy A Ruse1, Philip D Harvey2, Vicki G Davis1, Alexandra S Atkins1, Kolleen H Fox3, Richard S E Keefe4.   

Abstract

INTRODUCTION: Assessment of functional capacity is an intrinsic part of determining the functional relevance of response to treatment of cognitive impairment in schizophrenia. Existing methods are highly and consistently correlated with performance on neuropsychological tests, but most current assessments of functional capacity are still paper and pencil simulations. We developed a computerized virtual reality assessment that contains all of the components of a shopping trip.
METHODS: We administered the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) to 54 healthy controls and to 51 people with schizophrenia to test its feasibility. Dependent variables for the VRFCAT included time to completion and errors on 12 objectives and the number of times that an individual failed to complete an objective. The MATRICS Consensus Cognitive Battery (MCCB) and a standard functional capacity measure, the UCSD Performance-Based Skills Assessment-Brief (UPSA-B) were administered to the patients with schizophrenia.
RESULTS: Patients with schizophrenia performed more poorly than healthy controls on 10/11 of the time variables, as well as 2/12 error scores and 2/12 failed objectives. Pearson correlations for 7 of 15 VRFCAT variables with MCCB composite scores were statistically significant.
CONCLUSION: These results provide support for the possibility of computerized functional capacity assessment, but more substantial studies are required.

Entities:  

Keywords:  Cognitive Assessment; Computer Based Assessment; Functional Capacity; Schizophrenia; Virtual Reality

Year:  2014        PMID: 25083416      PMCID: PMC4113005          DOI: 10.1016/j.scog.2014.01.004

Source DB:  PubMed          Journal:  Schizophr Res Cogn        ISSN: 2215-0013


  29 in total

1.  UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Authors:  T L Patterson; S Goldman; C L McKibbin; T Hughs; D V Jeste
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

Review 2.  Late-life schizophrenia. What providers need to know.

Authors:  Phillips D Harvey; Christopher R Bowie
Journal:  Director       Date:  2005

Review 3.  Performance-based measures of functional skills: usefulness in clinical treatment studies.

Authors:  Philip D Harvey; Dawn I Velligan; Alan S Bellack
Journal:  Schizophr Bull       Date:  2007-05-09       Impact factor: 9.306

4.  Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder.

Authors:  Christopher R Bowie; Colin Depp; John A McGrath; Paula Wolyniec; Brent T Mausbach; Mary H Thornquist; James Luke; Thomas L Patterson; Philip D Harvey; Ann E Pulver
Journal:  Am J Psychiatry       Date:  2010-05-17       Impact factor: 18.112

5.  Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panel.

Authors:  Feea R Leifker; Thomas L Patterson; Robert K Heaton; Philip D Harvey
Journal:  Schizophr Bull       Date:  2009-06-12       Impact factor: 9.306

6.  Relationship of the Brief UCSD Performance-based Skills Assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder.

Authors:  Brent T Mausbach; Philip D Harvey; Ann E Pulver; Colin A Depp; Paula S Wolyniec; Mary H Thornquist; James R Luke; John A McGrath; Christopher R Bowie; Thomas L Patterson
Journal:  Bipolar Disord       Date:  2010-02       Impact factor: 6.744

7.  Assessing everyday functioning in schizophrenia: not all informants seem equally informative.

Authors:  Samir Sabbag; Elizabeth M Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson; Philip D Harvey
Journal:  Schizophr Res       Date:  2011-05-26       Impact factor: 4.939

8.  A virtual reality apartment as a measure of medication management skills in patients with schizophrenia: a pilot study.

Authors:  Matthew M Kurtz; Elizabeth Baker; Godfrey D Pearlson; Robert S Astur
Journal:  Schizophr Bull       Date:  2006-09-06       Impact factor: 9.306

Review 9.  The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

Authors:  Robert W Buchanan; Julie Kreyenbuhl; Deanna L Kelly; Jason M Noel; Douglas L Boggs; Bernard A Fischer; Seth Himelhoch; Beverly Fang; Eunice Peterson; Patrick R Aquino; William Keller
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

10.  Practically relevant research: capturing real world tasks, environments, and outcomes.

Authors:  Sara J Czaja; Joseph Sharit
Journal:  Gerontologist       Date:  2003-03
View more
  16 in total

1.  The impact of emotional faces on social motivation in schizophrenia.

Authors:  Sina Radke; Vera Pfersmann; Birgit Derntl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-02-28       Impact factor: 5.270

2.  Virtual reality assessment of functional capacity in people with Schizophrenia: Associations with reduced emotional experience and prediction of functional outcomes.

Authors:  Philip D Harvey; Anzalee Khan; Alexandra Atkins; Richard Se Keefe
Journal:  Psychiatry Res       Date:  2019-01-15       Impact factor: 3.222

3.  Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning.

Authors:  Joseph Ventura; Tamara Welikson; Arielle Ered; Kenneth L Subotnik; Richard S E Keefe; Gerhard S Hellemann; Keith H Nuechterlein
Journal:  Early Interv Psychiatry       Date:  2019-06-10       Impact factor: 2.732

4.  Online Social Cognition Training in Schizophrenia: A Double-Blind, Randomized, Controlled Multi-Site Clinical Trial.

Authors:  Mor Nahum; Hyunkyu Lee; Melissa Fisher; Michael F Green; Christine I Hooker; Joseph Ventura; Joshua T Jordan; Annika Rose; Sarah-Jane Kim; Kristen M Haut; Michael M Merzenich; Sophia Vinogradov
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

Review 5.  Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer's Disease Spectrum.

Authors:  Philip D Harvey; Stephanie Cosentino; Rosie Curiel; Terry E Goldberg; Jeffrey Kaye; David Loewenstein; Daniel Marson; David Salmon; Keith Wesnes; Holly Posner
Journal:  Innov Clin Neurosci       Date:  2017-02-01

6.  Assessment of Age-Related Differences in Functional Capacity Using the Virtual Reality Functional Capacity Assessment Tool (VRFCAT).

Authors:  A S Atkins; I Stroescu; N B Spagnola; V G Davis; T D Patterson; M Narasimhan; P D Harvey; R S E Keefe
Journal:  J Prev Alzheimers Dis       Date:  2015-06

7.  Validation of a Computerized test of Functional Capacity.

Authors:  Richard S E Keefe; Vicki G Davis; Alexandra S Atkins; Adam Vaughan; Tom Patterson; Meera Narasimhan; Philip D Harvey
Journal:  Schizophr Res       Date:  2016-04-16       Impact factor: 4.939

8.  Factor structure of cognitive performance and functional capacity in schizophrenia: Evidence for differences across functional capacity measures.

Authors:  Philip D Harvey; William P Horan; Alexandra S Atkins; Heather Stevens; Matthew Welch; Joshua Yuan; Thomas L Patterson; Meera Narasimhan; Richard S E Keefe
Journal:  Schizophr Res       Date:  2020-09-11       Impact factor: 4.939

9.  Randomized controlled trial of computer-based treatment of social cognition in schizophrenia: the TRuSST trial protocol.

Authors:  Annika Rose; Sophia Vinogradov; Melissa Fisher; Michael F Green; Joseph Ventura; Christine Hooker; Michael Merzenich; Mor Nahum
Journal:  BMC Psychiatry       Date:  2015-07-03       Impact factor: 3.630

10.  A Serious Game to Improve Cognitive Functions in Schizophrenia: A Pilot Study.

Authors:  Isabelle Amado; Lindsay Brénugat-Herné; Eric Orriols; Colombe Desombre; Maxine Dos Santos; Zelda Prost; Marie-Odile Krebs; Pascale Piolino
Journal:  Front Psychiatry       Date:  2016-04-20       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.